GFP-Human PC3 Prostate Adenocarcinoma Cells

GFP-Human PC3 Prostate Adenocarcinoma Cells are a specialized line of human PC3 prostate cancer cells that have been genetically engineered to continuously express green fluorescent protein (GFP). This modification allows researchers to study aggressive prostate cancer behaviors in a more dynamic way. These cells provide a robust model for investigating various aspects of cancer biology, including tumor growth, cellular migration, invasion into surrounding tissues, metastasis to distant sites, responses to therapeutic agents, and the complexities of both two-dimensional and three-dimensional cellular environments.

Originating from a metastatic bone lesion, PC3 cells are known for their adherence properties, making them an ideal choice for examining advanced, androgen-independent prostate cancer. The presence of GFP facilitates real-time visualization of the cells through advanced techniques such as fluorescence microscopy, which allows researchers to monitor cellular behavior directly. Additionally, flow cytometry and high-content imaging can be employed to quantify and analyze the characteristics of these cells.

Moreover, GFP expression enables researchers to track tumor development and progression in living organisms (in vivo) as well as in experimental settings outside the body (ex vivo), providing invaluable insights into cancer dynamics.

IMPORTANT: Quality warranty requires use of NeoBioPharma media. Biohazardous material despite negative pathogen testing. Quality claims must be reported within 1 month.